A Study of Stimulant Medications Infusion Through Midline Catheters Based on Real-world Data

Launched by SIR RUN RUN SHAW HOSPITAL · Jun 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well stimulant medications work when they are infused through midline catheters (MC) placed in specific veins, particularly the axillary and subclavian veins. The goal is to understand how different doses of these medications and the length of infusion impact complications related to the catheters. By studying this, researchers hope to improve safety guidelines for using these catheters, reduce the need for more invasive central venous catheters, and ultimately lower healthcare costs while ensuring patients receive effective treatment.

To be eligible for the trial, participants must be at least 18 years old and have a midline catheter placed in the right location. However, people who have had a central venous catheter placed at the same time as their midline catheter or those from vulnerable groups (like minors or critically ill patients) cannot participate. If you join the trial, you can expect to be part of a study that aims to help improve medical practices and patient safety regarding catheter use. This study has not started recruiting participants yet, so keep an eye out for updates if you're interested!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age greater than or equal to 18 years old.
• • In patients with conventional indwelling single-chamber three-way valve MC, the catheter tip is located in the axillary vein or subclavian vein of the chest wall segment.
• Exclusion Criteria:
• • Those who have been placed with a central venous catheter during MC insertion.
• • Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterates, etc.